Digestive Care, Inc. Announces FDA Labeling Revision Approval for PERTZYE(R) (pancrelipase)
BETHLEHEM, PA--(Marketwired - July 12, 2017) - Digestive Care, Inc. (DCI) and its marketing partner to support the U.S. cystic fibrosis (CF) community, Chiesi, today announced U.S. Food and Drug Administration (FDA) approval of a labeling revision to now …